Access cutting-edge urothelial carcinoma treatment through this clinical trial at a research site in Springfield. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Springfield location
Preparing your pre-screening questions…
Access urothelial carcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related urothelial carcinoma treatment provided free
Check if you qualify for this urothelial carcinoma clinical trial in Springfield, IL
No-Cost Study Care
Local to Springfield
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this study is to conduct the first randomized-controlled trial to determine the oncologic efficacy of lymph node dissection in participants with upper tract urothelial cell carcinoma. The main questions it aims to answer are: * To determine oncologic outcomes, specifically 2-year recurrence-free survival * To determine other oncologic outcomes including treatment-free, cancer-specific and overall survival * To determine time to recurrence and recurrence patterns * To determine use of adjuvant therapies * To determine perioperative complications Participants will undergo nephroureterectomy with or without lymph node dissection. Researchers will compare these two groups to determine the oncologic efficacy of performing lymph node dissection.
Sponsor: Case Comprehensive Cancer Center
Yes, this clinical trial (NCT06262516) has an active research site in Springfield, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for urothelial carcinoma treatment options in Springfield, IL, this clinical trial (NCT06262516) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Springfield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced urothelial carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all urothelial carcinoma clinical trials near you to find additional studies recruiting in your area.
See all bladder cancer clinical trials recruiting in Springfield — not just this study.
Browse Bladder Cancer Trials in Springfield →